Summary: Researchers demonstrated that the success of anti-CTLA-4 immunotherapy against brain tumors does not depend on local ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Subscribe to our newsletter for ...

A single drug shrank or eliminated tumors in 43 of 102 patients with advanced head-and-neck cancer that had stopped ...

Medical imaging routinely used in cancer care may hold far more biological information than previously thought. An international study involving Umeå University guest professor Lukas Kenner shows that ...

Mortality and morbidity rates remain high in head and neck cancer (HNC). Novel radiopharmaceuticals, injectable therapies, advances in systemic therapy, including novel immunomodulators and cell-based ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Two new studies, published ...